Ashley Gallagher, MA

Low-cost, monitoring-supported lifestyle intervention outperformed group-based health education and physical activity programs on cost and effectiveness.

A study found that community pharmacists are viewed as medication dispensers, with gaps in awareness screening, counseling, and other prevention services.

The combination of bictegravir and lenacapavir gives virologically suppressed adults with HIV a new option showing sustained viral suppression.

The once daily medication outperformed placebo across all 9 key secondary end points in the phase 3 VALOR trial.

Community pharmacy owners found that innovation readiness was associated with how quickly pharmacies rolled out remote services during the early pandemic.

Once maternal major depressive disorder is disentangled from drug exposure, SSRIs carry little or no added risk in pregnancy, according to analysis.

A tool now tracks measles, meningitis, and whooping cough at the state and substate level, giving pharmacists a new resource to identify local outbreaks.

The approval gives providers a second-generation integrase inhibitor to start eligible newborns with HIV-1 on therapy from birth.

Diabetes regimen adjustments for older adults with type 2 diabetes often do not align with glycemic goals, with deintensification remaining infrequent.

Strong first-season effectiveness against respiratory syncytial virus hospitalization but finds no protective benefit in year 2.

Giving 15-valent pneumococcal conjugate vaccine alongside acellular DTaP did not compromise antibody responses to either vaccine.

A once daily small-molecule GLP-1 receptor agonist showed dose-dependent weight loss with no apparent plateau at 36 weeks.

Oseltamivir treatment lowers the hazard of intensive care unit admission and shortens hospital stays in children hospitalized with influenza.

Analysis of tertiary care patients finds no difference in quality of life between those with functional somatic disorder and those with long COVID.

A study found that patients who sustained high adherence to glucose-lowering medication had a lower rate of major cardiovascular events over 10 years.

New analysis finds Black, Hispanic, unmarried, and Medicaid-enrolled women bore the heaviest burden of pandemic-related stressors during pregnancy.

Data show semaglutide's weight loss in patients without diabetes but show how its gastrointestinal tolerability and efficacy compare with other GLP-1s.

Pharmacists navigate ACIP changes, legal battles, and shifting vaccine schedules reshaping US immunization policy and respiratory season planning.

Pharmacists detail a simple, tech-driven revenue cycle management workflow that empowers pharmacies to bill, reconcile, and get paid for clinical services.

New data show illness perception and functional capacity influence each other in older adults with COPD and diabetes after hospital discharge.

Data show that TyG-WC, an index combining insulin resistance and central adiposity, is the only surrogate marker independently linked to osteoporosis.

Policy shifts in Medicare and advancements in automation are creating a massive opportunity for both revenue growth and clinical impact.

A year of ACIP turnover, schedule changes, and lawsuits has fractured US vaccine guidance—and tied pharmacists' scope and billing to a moving target.

The current crisis of staffing shortage is not just a labor shortage but a structural failure in how pharmacies recruit and value their technician workforce.

The expanded approval adds a self-administered autoinjector option and new label language tying LDL-C lowering to reduced cardiovascular risk.

Although DSCSA is often viewed as a regulatory burden, pharmacy leaders illustrate its necessity through harrowing case studies of supply chain failures.

Pharmacy leaders urge regional alliances, scalable clinical services, and data exchange to make pharmacist care reimbursable and routine.

Rural pharmacist explains how local pharmacies close care gaps in older, rural patients by improving vaccine access, education, and on-time immunizations.

Pharmacists must navigate peptide and GLP-1 compounding legally by understanding 503A vs 503B rules.

The academy's updated influenza guidance arrives days after a White House executive order narrowed the recommended childhood vaccine schedule.